We were able to interpolate thirty-three available fundamentals for Medicure, which can be compared to its peers in the industry. The stock experiences a very speculative upward sentiment. Check odds of Medicure to be traded at C$1.1125 in 90 days. Key indicators impacting Medicure's financial strength include:
Please note, the imprecision that can be found in Medicure's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Medicure. Check Medicure's Beneish M Score to see the likelihood of Medicure's management manipulating its earnings.
Medicure Stock Summary
Medicure competes with Biosyent, Covalon Technologies, Cipher Pharmaceuticals, and Knight Therapeutics. Medicure Inc., a pharmaceutical company, engages in the development and commercialization of therapies for the cardiovascular market in the United States. The company was founded in 1997 and is headquartered in Winnipeg, Canada. MEDICURE INC operates under Biotechnology classification in Canada and is traded on TSX Venture Exchange.
Foreign Associate
UK
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
You should never invest in Medicure without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Medicure Stock, because this is throwing your money away. Analyzing the key information contained in Medicure's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Medicure Key Financial Ratios
There are many critical financial ratios that Medicure's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Medicure reports annually and quarterly.
Comparative valuation techniques use various fundamental indicators to help in determining Medicure's current stock value. Our valuation model uses many indicators to compare Medicure value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medicure competition to find correlations between indicators driving Medicure's intrinsic value. More Info.
Medicure is regarded fourth in return on equity category among its peers. It also is regarded fourth in return on asset category among its peers . At this time, Medicure's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medicure's earnings, one of the primary drivers of an investment's value.
Medicure Systematic Risk
Medicure's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Medicure volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Medicure correlated with the market. If Beta is less than 0 Medicure generally moves in the opposite direction as compared to the market. If Medicure Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Medicure is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Medicure is generally in the same direction as the market. If Beta > 1 Medicure moves generally in the same direction as, but more than the movement of the benchmark.
Medicure Total Assets Over Time
Today, most investors in Medicure Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Medicure's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Medicure growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Medicure help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Medicure. We use our internally-developed statistical techniques to arrive at the intrinsic value of Medicure based on widely used predictive technical indicators. In general, we focus on analyzing Medicure Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Medicure's daily price indicators and compare them against related drivers.
When running Medicure's price analysis, check to measure Medicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicure is operating at the current time. Most of Medicure's value examination focuses on studying past and present price action to predict the probability of Medicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicure's price. Additionally, you may evaluate how the addition of Medicure to your portfolios can decrease your overall portfolio volatility.